Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2014-09-05 00:56 2014-09-02 RMD RESMED INC Douglas Robert Andrew Officer OPT+S $53.00 8,000 $423,978 38,630
2014-09-04 23:02 2014-09-02 IART INTEGRA LIFESCIENCES HOLDINGS CORP OGRADY JUDITH Officer SELL $49.82 2,500 $124,560 10,706
2014-09-04 23:40 2014-09-02 PODD INSULET CORP DeSisto Duane Director, Officer OPT+S $36.30 20,000 $725,998 257,184
2014-09-03 23:54 2014-09-02 CRY Artivion Inc. ANDERSON STEVEN G Officer SELL $10.08 20,000 $201,502 1,346,333
2014-09-04 03:57 2014-08-22 RMD RESMED INC Reiser Anne Officer OPT+S $53.37 3,000 $160,116 66,524
2014-09-03 22:45 2014-09-02 TNDM TANDEM DIABETES CARE INC Sheridan John F Officer OPT+S $13.99 2,000 $27,984 1,198
2014-09-03 20:19 2014-08-29 SYK STRYKER CORP STRYKER RONDA E Director SELL $83.23 21,000 $1,747,820 10,776,682
2014-09-03 23:11 2014-09-02 BSX BOSTON SCIENTIFIC CORP MARIO ERNEST Director SELL $12.60 10,000 $125,992 277,855
2014-09-04 02:04 2014-09-02 CTSO Cytosorbents Corp Kraus Al Director OPT+S $0.25 50,000 $12,480 1,393,631
2014-09-04 02:01 2014-09-02 CTSO Cytosorbents Corp BLOCH KATHLEEN P. Officer BUY $0.23 65,000 $14,723 175,000
2014-09-02 19:16 2014-08-28 HAE HAEMONETICS CORP McDaniel Kathleen Officer SELL $35.46 406 $14,396 5,013
2014-09-03 02:24 2014-08-28 CTSO Cytosorbents Corp Gunton James T. Director SELL $0.24 214,387 $50,574 1,532,601
2014-09-03 01:15 2014-08-28 DXCM DEXCOM INC KAHN BARBARA Director SELL $44.52 4,000 $178,092 49,525
2014-09-03 00:01 2014-08-29 CMXI Nuo Therapeutics, Inc. TOZER DEAN Officer BUY $0.35 40,000 $14,000 126,700
2014-08-29 19:17 2014-08-27 SYK STRYKER CORP STRYKER RONDA E Director SELL $82.44 14,000 $1,154,173 10,797,682
2014-08-28 23:00 2014-08-27 IART INTEGRA LIFESCIENCES HOLDINGS CORP GORELICK RICHARD D. Officer SELL $50.03 7,000 $350,210 13,597
2014-08-29 01:25 2014-08-26 CTSO Cytosorbents Corp Gunton James T. Director SELL $0.24 1,360,000 $328,304 1,746,988
2014-08-29 00:32 2014-08-26 DXCM DEXCOM INC LORD JONATHAN T MD Director OPT+S $45.56 20,000 $911,240 137,107
2014-08-29 00:32 2014-08-26 DXCM DEXCOM INC MOY JEFFREY Officer OPT+S $45.30 16,663 $754,836 97,916
2014-08-29 00:31 2014-08-26 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer, 10% owner SELL $46.05 5,000 $230,267 640,389
2014-08-27 22:53 2014-08-27 INFU InfuSystem Holdings, Inc Steen Eric K Director, Officer BUY $2.75 15,000 $41,250 71,184
2014-08-27 21:16 2014-08-25 SYK STRYKER CORP STRYKER RONDA E Director SELL $82.80 14,000 $1,159,180 10,811,682
2014-08-28 00:59 2014-08-25 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $44.12 10,000 $441,243 159,205
2014-08-28 00:58 2014-08-25 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer OPT+S $44.35 4,000 $177,406 126,582
2014-08-28 00:57 2014-08-25 DXCM DEXCOM INC Pacelli Steven Robert Officer OPT+S $44.56 30,000 $1,336,860 241,399
2014-08-27 13:13 2014-08-26 CMXI Nuo Therapeutics, Inc. SHALLCROSS STEVEN A Officer BUY $0.38 27,500 $10,450 79,500
2014-08-27 00:01 2014-08-25 CRY Artivion Inc. Anderson Bruce G. Officer OPT+S $10.05 5,000 $50,255 34,564
2014-08-27 04:04 2014-08-22 RMD RESMED INC Reiser Anne Officer OPT+S $51.86 2,000 $103,716 66,524
2014-08-26 23:00 2014-08-25 IART INTEGRA LIFESCIENCES HOLDINGS CORP HENNEMAN JOHN B III Officer SELL $50.12 20,000 $1,002,338 34,159
2014-08-27 00:15 2014-08-25 CTSO Cytosorbents Corp Kraus Al Director OPT+S $0.25 100,000 $24,960 1,393,631
2014-08-25 20:42 2014-08-21 SYK STRYKER CORP STRYKER RONDA E Director SELL $82.34 14,000 $1,152,735 10,825,682
2014-08-25 23:00 2014-08-22 IART INTEGRA LIFESCIENCES HOLDINGS CORP LEONETTI DEBORAH A Officer SELL $50.96 1,000 $50,961 9,774
2014-08-26 00:15 2014-08-21 DXCM DEXCOM INC VALDES JORGE A Officer SELL $43.58 10,671 $465,040 64,195
2014-08-26 00:14 2014-08-22 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer, 10% owner OPT+S $44.46 13,607 $604,914 645,389
2014-08-26 00:13 2014-08-22 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $44.24 20,000 $884,722 159,205
2014-08-26 00:16 2014-08-22 CMXI Nuo Therapeutics, Inc. TOZER DEAN Officer BUY $0.38 38,700 $14,706 86,700
2014-08-22 02:49 2014-08-20 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer, 10% owner OPT+S $44.36 23,893 $1,059,822 395,626
2014-08-22 02:49 2014-08-21 DXCM DEXCOM INC KAHN BARBARA Director SELL $43.42 2,200 $95,524 53,525
2014-08-22 00:18 2014-08-20 CMXI Nuo Therapeutics, Inc. ROSENDALE MARTIN P Director, Officer BUY $0.40 25,000 $10,000 229,149
2014-08-22 00:17 2014-08-20 CMXI Nuo Therapeutics, Inc. TOZER DEAN Officer BUY $0.39 48,000 $18,720 48,000
2014-08-22 00:16 2014-08-20 CMXI Nuo Therapeutics, Inc. SHALLCROSS STEVEN A Officer BUY $0.39 52,000 $20,280 52,000
2014-08-22 03:54 2014-08-20 WST WEST PHARMACEUTICAL SERVICES INC GAILEY JOHN R Officer OPT+S $43.96 20,000 $879,194 67,856
2014-08-22 03:45 2014-08-21 WST WEST PHARMACEUTICAL SERVICES INC LUZZI RICHARD D Officer SELL $44.07 10,000 $440,721 90,795
2014-08-22 03:27 2014-08-19 WST WEST PHARMACEUTICAL SERVICES INC ANDERSON MICHAEL A Officer OPT+S $43.41 9,800 $425,441 67,313
2014-08-20 17:10 2014-08-14 PETV PetVivo Holdings, Inc. Dolan John F. Director, Officer BUY $0.01 2,666,667 $16,000 363,393,390
2014-08-20 23:38 2014-08-20 SYK STRYKER CORP STRYKER RONDA E Director SELL $81.01 7,000 $567,083 10,839,682
2014-08-21 03:58 2014-08-18 RMD RESMED INC PACE GARY W Director OPT+S $51.60 25,000 $1,290,050 88,273
2014-08-21 03:11 2014-08-18 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer, 10% owner OPT+S $44.61 150,000 $6,691,815 652,889
2014-08-21 03:09 2014-08-18 DXCM DEXCOM INC ROPER JESS Officer OPT+S $43.95 8,000 $351,628 88,213
2014-08-21 03:08 2014-08-19 DXCM DEXCOM INC DOUBLEDAY RICHARD Officer OPT+S $45.01 20,000 $900,278 126,582
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.